Ver registro no DEDALUS
Exportar registro bibliográfico



CD14 and IL6 polymorphisms are associated with a pro-atherogenic profile in young adults with acute myocardial infarction (2013)

  • Authors:
  • USP Schools: FCF; FCF; FCF
  • DOI: 10.1007/s11239-012-0841-4
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s11239-012-0841-4 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Versões disponíveis em Acesso Aberto do: 10.1007/s11239-012-0841-4 (Fonte: Unpaywall API)

    Título do periódico: Journal of Thrombosis and Thrombolysis

    ISSN: 0929-5305,1573-742X

      Não possui versão em Acesso aberto
    Informações sobre o Citescore
  • Título: Journal of Thrombosis and Thrombolysis

    ISSN: 0929-5305

    Citescore - 2017: 2.3

    SJR - 2017: 0.991

    SNIP - 2017: 0.899

  • How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      LIMA NETO, Lidio Gonçalves; HIRATA, Rosario Dominguez Crespo; LUCHESSI, André Ducati; et al. CD14 and IL6 polymorphisms are associated with a pro-atherogenic profile in young adults with acute myocardial infarction. Journal of Thrombosis and Thrombolysis, Dordrecht, v. 36, n. 3, p. 332-240, 2013. Disponível em: < > DOI: 10.1007/s11239-012-0841-4.
    • APA

      Lima Neto, L. G., Hirata, R. D. C., Luchessi, A. D., Silbiger, V. N., Stephano, M. A., Sampaio, M. F., et al. (2013). CD14 and IL6 polymorphisms are associated with a pro-atherogenic profile in young adults with acute myocardial infarction. Journal of Thrombosis and Thrombolysis, 36( 3), 332-240. doi:10.1007/s11239-012-0841-4
    • NLM

      Lima Neto LG, Hirata RDC, Luchessi AD, Silbiger VN, Stephano MA, Sampaio MF, Armaganijan D, Hirata MH. CD14 and IL6 polymorphisms are associated with a pro-atherogenic profile in young adults with acute myocardial infarction [Internet]. Journal of Thrombosis and Thrombolysis. 2013 ; 36( 3): 332-240.Available from:
    • Vancouver

      Lima Neto LG, Hirata RDC, Luchessi AD, Silbiger VN, Stephano MA, Sampaio MF, Armaganijan D, Hirata MH. CD14 and IL6 polymorphisms are associated with a pro-atherogenic profile in young adults with acute myocardial infarction [Internet]. Journal of Thrombosis and Thrombolysis. 2013 ; 36( 3): 332-240.Available from:

    Referências citadas na obra
    Corrado E et al (2010) An update on the role of markers of inflammation in atherosclerosis. J Atheroscler Thromb 17(1):1–11
    Tousoulis D et al (2012) The role of nitric oxide on endothelial function. Curr Vasc Pharmacol 10(1):4–18
    Lee S et al (2011) Effects of interventions on oxidative stress and inflammation of cardiovascular diseases. World J Cardiol 3(1):18–24
    Tan J et al (2009) Prognostic value of interleukin-6 during a 3-year follow-up in patients with acute ST-segment elevation myocardial infarction. Heart Vessels 24(5):329–334
    Mann DL et al (2010) Innate immunity in the adult mammalian heart: for whom the cell tolls. Trans Am Clin Climatol Assoc 121:34–50
    Hodgkinson CP, Ye S (2011) Toll-like receptors, their ligands, and atherosclerosis. ScientificWorldJournal 11:437–453
    Peri F et al (2010) Exploring the LPS/TLR4 signal pathway with small molecules. Biochem Soc Trans 38(5):1390–1395
    Olivieri F et al (2006) Genetic polymorphisms of inflammatory cytokines and myocardial infarction in the elderly. Mech Ageing Dev 127(6):552–559
    Brull DJ et al (2001) Interleukin-6 gene −174g>c and −572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 21(9):1458–1463
    Sanderson SC et al (2009) Association between IL6 gene variants −174G>C and −572G>C and serum IL-6 levels: interactions with social position in the Whitehall II cohort. Atherosclerosis 204(2):459–464
    Manginas A et al (2008) Inflammatory cytokine gene variants in coronary artery disease patients in Greece. Coron Artery Dis 19(8):575–582
    Vakili H et al (2011) Genetic polymorphism of interleukin-6 gene and susceptibility to acute myocardial infarction. Coron Artery Dis 22(5):299–305
    Koenig W et al (2002) CD14 C(−260)–>T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery disease. J Am Coll Cardiol 40(1):34–42
    Rizzello V et al (2010) Role of the CD14 C(−260)T promoter polymorphism in determining the first clinical manifestation of coronary artery disease. J Cardiovasc Med (Hagerstown) 11(1):20–25
    Hermann M et al (2012) CRP and CD14 polymorphisms correlate with coronary plaque volume in patients with coronary artery disease–IVUS substudy of the ENCORE trials. Atherosclerosis 220(1):172–176
    Shimada K et al (2000) Common polymorphism in the promoter of the CD14 monocyte receptor gene is associated with acute myocardial infarction in Japanese men. Am J Cardiol 86(6):682–684 A8
    Balistreri CR et al (2009) TLR4 polymorphisms and ageing: implications for the pathophysiology of age-related diseases. J Clin Immunol 29(4):406–415
    Smirnova I et al (2000) Phylogenetic variation and polymorphism at the toll-like receptor 4 locus (TLR4). Genome Biol 1(1):RESEARCH002.1–RESEARCH002.10
    Kiechl S et al (2002) Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347(3):185–192
    Boekholdt SM et al (2003) Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events. Circulation 107(19):2416–2421
    Ameziane N et al (2003) Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events. Arterioscler Thromb Vasc Biol 23(12):e61–e64
    Balistreri CR et al (2004) Role of Toll-like receptor 4 in acute myocardial infarction and longevity. JAMA 292(19):2339–2340
    Fukushima R et al (2009) Expression levels of Toll-like receptor genes in coronary atherosclerotic lesions of patients with acute coronary syndrome or stable angina pectoris. Circ J 73(8):1479–1484
    Kablak-Ziembicka A et al (2011) Relationship between carotid intima-media thickness, cytokines, atherosclerosis extent and a two-year cardiovascular risk in patients with arteriosclerosis. Kardiol Pol 69(10):1024–1031
    Lopez-Mejias R et al (2011) Lack of association between IL6 single nucleotide polymorphisms and cardiovascular disease in Spanish patients with rheumatoid arthritis. Atherosclerosis 219(2):655–658
    Edfeldt K et al (2004) Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction. Eur Heart J 25(16):1447–1453
    Mendis S et al (2011) World Health Organization definition of myocardial infarction: 2008–09 revision. Int J Epidemiol 40(1):139–146
    Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser, 2000. 894: p. i–xii, 1–253
    Hanon O et al (2000) Are the 1999 World Health Organization-International Society of Hypertension recommendations applicable to clinical practice? Arch Mal Coeur Vaiss 93(8):953–957
    Sampaio MF et al (2007) AMI is associated with polymorphisms in the NOS3 and FGB but not in PAI-1 genes in young adults. Clin Chim Acta 377(1–2):154–162
    Salazar LA et al (1998) Optimized procedure for DNA isolation from fresh and cryopreserved clotted human blood useful in clinical molecular testing. Clin Chem 44(8 Pt 1):1748–1750
    Lima-Neto LG et al (2009) Detection of the TLR4 1196C>T polymorphism by mismatched-polymerase chain reaction using plasmid DNA as internal control in restriction fragment length polymorphism assays. Genet Test Mol Biomarkers 13(3):343–347
    Chapman CM et al (2003) Association of an allelic variant of interleukin-6 with subclinical carotid atherosclerosis in an Australian community population. Eur Heart J 24(16):1494–1499
    Ortlepp JR et al (2005) Additive effects of the chemokine receptor 2, vitamin D receptor, interleukin-6 polymorphisms and cardiovascular risk factors on the prevalence of myocardial infarction in patients below 65 years. Int J Cardiol 105(1):90–95
    Panoulas VF et al (2009) Association of interleukin-6 (IL-6)-174G/C gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis: the role of obesity and smoking. Atherosclerosis 204(1):178–183
    Arroyo-Espliguero R et al (2005) CD14 C(−260)T promoter polymorphism and prevalence of acute coronary syndromes. Int J Cardiol 98(2):307–312
    Bernardo E et al (2006) Influence of the CD14 C260T promoter polymorphism on C-reactive protein levels in patients with coronary artery disease. Am J Cardiol 98(9):1182–1184
    Porsch-Ozcurumez M et al (2007) Post hoc analysis on the CD14 C(−260)T promoter polymorphism and coronary heart disease. Physiol Res 56(6):727–733
    Garcia-Bermudez M et al (2012) Lack of association between TLR4 rs4986790 polymorphism and risk of cardiovascular disease in patients with rheumatoid arthritis. DNA Cell Biol 31(7):1214–1220
    Koch W et al (2006) Toll-like receptor 4 gene polymorphisms and myocardial infarction: no association in a Caucasian population. Eur Heart J 27(21):2524–2529
    Riikola A et al (2009) Interleukin-6 promoter polymorphism and cardiovascular risk factors: the Health 2000 Survey. Atherosclerosis 207(2):466–470
    Shen J et al (2008) The effect of IL6-174C/G polymorphism on postprandial triglyceride metabolism in the GOLDN studyboxs. J Lipid Res 49(8):1839–1845
    Ljungman P et al (2009) DNA variants, plasma levels and variability of interleukin-6 in myocardial infarction survivors: results from the AIRGENE study. Thromb Res 124(1):57–64
    Watt MJ et al (2005) Hormone-sensitive lipase is reduced in the adipose tissue of patients with type 2 diabetes mellitus: influence of IL-6 infusion. Diabetologia 48(1):105–112
    Miranville A et al (2010) Reversal of inflammation-induced impairment of glucose uptake in adipocytes by direct effect of CB1 antagonism on adipose tissue macrophages. Obesity (Silver Spring) 18(12):2247–2254
    Amar J et al (2004) CD14 C(−260)T gene polymorphism, circulating soluble CD14 levels and arteriosclerosis. J Hypertens 22(8):1523–1528
    Giacconi R et al (2007) CD14 C (−260)T polymorphism, atherosclerosis, elderly: role of cytokines and metallothioneins. Int J Cardiol 120(1):45–51
    Krimbou L, Marcil M, Genest J (2006) New insights into the biogenesis of human high-density lipoproteins. Curr Opin Lipidol 17(3):258–267
    Tall AR (2008) Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins. J Intern Med 263(3):256–273
    Morange PE et al (2004) TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: the PRIME Study. Eur J Hum Genet 12(12):1041–1049
    Stoica AL et al (2010) Interleukin-6 and interleukin-10 gene polymorphism, endothelial dysfunction, and postoperative prognosis in patients with peripheral arterial disease. J Vasc Surg 52(1):103–109
    Labrum R et al (2007) Toll receptor polymorphisms and carotid artery intima-media thickness. Stroke 38(4):1179–1184
    Tonet AC et al (2008) Association between the −174 G/C promoter polymorphism of the interleukin-6 gene and cardiovascular disease risk factors in Brazilian older women. Braz J Med Biol Res 41(1):47–53
    Banerjee I et al (2009) Association between inflammatory gene polymorphisms and coronary artery disease in an Indian population. J Thromb Thrombolysis 27(1):88–94